Developed entirely by Eli Lilly, it activates GLP-1 receptors, glucagon receptors, and GIP (glucose-dependent insulinotropic polypeptide) receptors
The research case for GHK-Cu is built on several pillars: demonstrated collagen stimulation (up to 70% in laboratory models), wound healing acceleration across multiple tissue types, gene expression modulation affecting approximately 4,000 human genes, anti-inflammatory activity, and antioxidant defense support
, ,
And eventually, great discoveries will be made, maybe not at the same velocity
At Venturis Clinic, we offer IV ozone infusions and EBOO therapy (Extracorporeal Blood Oxygenation and Ozonation) a cutting-edge treatment that filters and reoxygenates the blood while helping to gently reset the immune system
If you have questions about a specific CoA or need additional documentation, our support team is happy to help at [email protected]